Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer [NA]
A clinical trial evaluating stereotactic body radiation therapy for hepatocellular carcinoma has terminated, and results have been posted.
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions
This clinical trial update discusses a noninvasive breath test being studied to detect liver cancer and monitor liver conditions, with recru…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone [Phase 2]
Randomized Phase II trial comparing MTL-CEBPA plus Sorafenib to Sorafenib alone in hepatocellular carcinoma; the study includes patients wit…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
This post-approval study by Boston Scientific evaluates methods to calculate the radiation-absorbed dose of Tc-99m MAA when used with TheraS…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC) [EARLY_Phase 1]
An early-phase Phase 1 clinical trial update noting that recruitment is ongoing for hepatic intra-arterial therapy in hepatocellular carcino…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of activated T lymphocytes (ATL) in hepatocellular carcinoma is currently recruiti…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study
An ongoing prospective cohort study evaluating urine proteomics-based dynamic surveillance to detect early recurrence after radical surgery …
-
FDA approval · 2025-03-05FDA Approved: EOVIST — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved Bayer's supplemental application for EOVIST (gadoxetate disodium), updating its labeling related to use in MRI for detecting fo…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer [Phase 1]
A first-in-human Phase 1 study of TORL-4-500 for advanced cancers is currently recruiting, including hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) [Phase 1]
Phase 1 study evaluating intravenous livmoniplimab in combination with budigalimab in adults with locally advanced or metastatic hepatocellu…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Personalized DC Vaccine for Postoperative Cancer [Phase 1]
A Phase 1 clinical trial evaluating a personalized dendritic cell vaccine for postoperative gastric cancer and hepatocellular carcinoma is c…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial evaluating transarterial chemoembolization (TACE) combined with an anti-PD-1 antibody for advanced hepatocellular carcinoma …
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Evaluate the Effect of Tirazamine on Primary Liver Cancer. [Phase 1, Phase 2]
A Phase 1/2 trial evaluating tirazamine for hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating cryoablation in combination with tislelizumab and lenvatinib as second-line or later therapy for adva…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization [Phase 1, Phase 2]
Clinical trial update for FB-1603 in hepatocellular carcinoma patients undergoing transarterial chemoembolization (Phase 1/Phase 2; recruiti…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT [Phase 3]
A Phase III randomized trial comparing radiotherapy plus toripalimab against sorafenib in advanced hepatocellular carcinoma with portal vein…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC [Phase 2, Phase 3]
The study evaluating nivolumab in combination with transarterial chemoembolization/chemoembolization for intermediate-stage hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma [Phase 3]
The Phase 3 trial comparing Seocalcitol to placebo for adjuvant treatment of hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma [NA]
A trial evaluating Seocalcitol versus placebo in advanced hepatocellular carcinoma was terminated.
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
This entry notes a Phase I/II clinical trial evaluating AST-3424 in subjects with advanced solid tumors and hepatocellular carcinoma, with t…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCC [Phase 2]
Phase 2 study evaluating a triple combination of Ociperlimab, Tislelizumab, and BAT1706 in advanced hepatocellular carcinoma has completed w…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma [Phase 3]
This is a Phase 3 clinical trial evaluating HLX13 versus YERVOY as first-line therapy for unresectable hepatocellular carcinoma, focusing on…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR) [Phase 1]
The Phase 1 trial of glypican-3–specific CAR-T cells (GLYCAR) for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 trial evaluating atezolizumab plus bevacizumab, with or without external beam radiotherapy…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials [NA]
This clinical trial update describes diversity and inclusion initiatives in prevention and therapy trials, with ongoing recruitment for stud…